about
The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodiesGAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilizationData mining the p53 pathway in the Fugu genome: evidence for strong conservation of the apoptotic pathway.Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitorThe fourth isoform of the adenine nucleotide translocator inhibits mitochondrial apoptosis in cancer cells.Insights into the mitochondrial signaling pathway: what lessons for chemotherapy?Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIA.PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.The modulation of inter-organelle cross-talk to control apoptosis.Therapeutic peptides: Targeting the mitochondrion to modulate apoptosis.PML, SUMOylation, and SenescenceA nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells.Chemosensitization by knockdown of adenine nucleotide translocase-2.Specific TP53 mutation pattern in radiation-induced sarcomas.PML is a ROS sensor activating p53 upon oxidative stress.The small GTPase Rac1 is a novel binding partner of Bcl-2 and stabilizes its antiapoptotic activity.PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3.Small ubiquitin-related modifier paralogs are indispensable but functionally redundant during early development of zebrafish.A Promyelocytic Leukemia Protein-Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma.Clearance of PML/RARA-bound promoters suffice to initiate APL differentiationRXR, un cofacteur essentiel à la transformation dans les leucémies aiguës promyélocytairesChange of Conformation of the DNA-binding Domain of p53 Is the Only Key Element for Binding of and Interference with p73Monoclonal antibodies raised against Xenopus p53 interact with human p73
P50
Q26853348-00AFE044-032D-4310-9D46-9305DEAF5698Q28271053-DF18DBDD-DEC0-486D-9839-B05FB3C16917Q30816662-0DF9581B-3B00-4E8D-8FC0-F13A9E604D74Q33840412-06449BFE-7DF5-495B-9239-F4B2AD58AEE8Q34091812-D1EF605D-2A80-4A85-950F-978960558C17Q35131580-FB84BCCA-4A65-49B3-8B16-D999BEE73CFCQ36118687-647E04B5-61A9-48C2-B78A-0962C755B4E1Q36305932-6ACE145B-A6AC-41F6-9607-6A5E4F9C6064Q36513159-84319B94-0A86-4CC0-B981-174074F4890DQ36575034-6EEC0B22-3AD2-4274-97D8-EF2D5A12E7CAQ36981640-905CAC94-8E50-4B50-A2A4-A2E586350222Q40079046-E565311B-73C6-4359-9DF1-627CC68ACBF6Q40230472-AFC29C7A-B396-4E1B-A1FE-44BAB8F38A99Q40313361-9CB1428D-8300-499D-BA71-441DAC45A6BAQ42515492-714B071B-74BC-4AD3-A101-D09E2DF90855Q42812047-31990FBC-CB1F-47D1-ADA4-CCF89A367242Q42978007-4E30FA20-BD5C-4B15-BB3E-1A8697A32DFCQ43286701-F01BABE7-B38D-4EF0-806E-12BAB2E646E1Q51465053-7D07BB30-C329-40C1-A95A-9234F7C98597Q57778782-B8129171-B08E-438B-A159-0E48DE94D8CDQ57778786-855F560A-14A6-4DBA-A08D-B82F53A56938Q57778801-69ACE37A-20F5-4D50-A545-83089128D249Q57778803-BCB11487-439F-4DF8-BE9E-3094B57A0DA0
P50
description
Frans medisch onderzoeker
@nl
French medical researcher
@en
investigadora médica francesa
@ast
name
Morgane Le Bras
@ast
Morgane Le Bras
@ca
Morgane Le Bras
@en
Morgane Le Bras
@es
Morgane Le Bras
@fr
Morgane Le Bras
@nl
Morgane Le Bras
@sl
type
label
Morgane Le Bras
@ast
Morgane Le Bras
@ca
Morgane Le Bras
@en
Morgane Le Bras
@es
Morgane Le Bras
@fr
Morgane Le Bras
@nl
Morgane Le Bras
@sl
prefLabel
Morgane Le Bras
@ast
Morgane Le Bras
@ca
Morgane Le Bras
@en
Morgane Le Bras
@es
Morgane Le Bras
@fr
Morgane Le Bras
@nl
Morgane Le Bras
@sl
P269
P1412
P2002
lebras_morgane
P2038
Morgane_Le_Bras2
P21
P213
0000 0001 4005 8520
P214
1425152636241220052411
P269
P27
P31
P496
0000-0003-4317-5591
P569
2000-01-01T00:00:00Z
P735
P7859
viaf-209258119